Alpha 2.0
Login Register
» Authors » Karin E Finberg

Karin E Finberg

Explore the profile of Karin E Finberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 1155
Followers 0
Related Specialties
Hematology
Oncology
Molecular Biology
Top 10 Co-Authors
XiuQi Li
Carsten A Wagner
John P Geibel
Zenta Walther
Larisa Lozovatsky
Jeffrey L Sklar
Richard P Lifton
A John Iafrate
Mark D Fleming
Dennis Brown
Published In
Blood
Lancet Oncol
J Mol Diagn
Haematologica
Hematol Oncol Clin North Am
Affiliations
Soon will be listed here.
Recent Articles
1.
Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia
Li X, Lozovatsky L, Tommasini S, Fretz J, Finberg K
Blood Adv . 2023 Jul; 7(17):5156-5171. PMID: 37417950
Iron deficiency is a potent stimulator of fibroblast growth factor 23 (FGF23), a hormonal regulator of phosphate and vitamin D metabolism, that is classically thought to be produced by bone-embedded...
2.
Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population
Jiao J, Finberg K, Jain D, Morotti R
Pediatr Dev Pathol . 2023 Jun; 26(4):394-403. PMID: 37334553
Background: Hepatocellular adenoma (HCA) in the pediatric population is very rare and there are only limited studies, especially with molecular characterization of the tumors. Main HCA subtypes recognized in the...
3.
Blocking (iron) traffic in the gut
Finberg K
Blood . 2022 Apr; 139(16):2424-2425. PMID: 35446376
No abstract available.
4.
Yale Precision Medicine Tumor Board: reawakening the guardian of the genome
Grant M, Finberg K, Walther Z, Stein S, Lacy J, Eder J, et al.
Lancet Oncol . 2022 Mar; 23(3):337-338. PMID: 35240081
No abstract available.
5.
Pathogenic BRCA2 germline variants in combined hepatocellular-cholangiocarcinoma
Li H, Zhang X, Finberg K, Walther Z, Jain D, Gibson J
Pathol Int . 2021 Nov; 72(2):138-140. PMID: 34808016
No abstract available.
6.
Endometrial Carcinoma as the Presenting Malignancy in a Teenager With a Pathogenic TP53 Germline Mutation: A Case Report and Literature Review
Irshaid L, Clark M, Fadare O, Finberg K, Parkash V
Int J Gynecol Pathol . 2021 May; 41(3):258-267. PMID: 33990091
Patients with germline TP53 mutations are characterized by the occurrence of multiple early-onset malignancies. The characteristic syndrome is Li-Fraumeni syndrome (OMIM # 151623), an autosomal dominant disorder typified by premenopausal...
7.
Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan
Gibson J, Finberg K, Nalbantoglu I, Cecchini M, Ganzak A, Walther Z, et al.
Lancet Oncol . 2021 Mar; 22(3):306-307. PMID: 33662283
No abstract available.
8.
Ironing out an approach to alleviate the hypoferremia of acute inflammation
Finberg K
Haematologica . 2021 Feb; 106(2):326-328. PMID: 33522782
No abstract available.
9.
Functional characterization of a novel SLC40A1 Arg88Ile mutation in a kindred with familial iron overload treated by phlebotomy
Womack J, Sukumaran A, Li X, Lozovatsky L, Gallagher P, Seid J, et al.
Blood Cells Mol Dis . 2021 Jan; 87:102532. PMID: 33385755
No abstract available.
10.
Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing
Hafez N, Walther Z, Eder J, Sklar J, Gettinger S, Finberg K, et al.
Lancet Oncol . 2020 Sep; 21(3):343-344. PMID: 32950226
No abstract available.